TY  - GEN
AU  - Hong,David S
AU  - Kurzrock,Razelle
AU  - Mulay,Marilyn
AU  - Rasmussen,Erik
AU  - Wu,Benjamin M
AU  - Bass,Michael B
AU  - Zhong,Zhandong D
AU  - Friberg,Greg
AU  - Rosen,Lee S
TI  - A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours
SN  - 1949-2553
PY  - 2015///0825
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - Cohort Studies
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Niacinamide
KW  - Oligonucleotides
KW  - Recombinant Fusion Proteins
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.2568
ER  -